A histologic scoring system for prognosis of patients with alcoholic hepatitis.
【译】组织学评分系统对酒精性肝炎患者的预后。
Methods Carry on retrospective analysis research to the sufferer's clinical data of 72 cases alcoholic hepatitis.
方法对72例酒精性肝炎患者的临床资料进行回顾性分析研究。
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
里尔模型：类固醇为重度酒精性肝炎患者的治疗策略的新工具。
Hepatology Digest: Will you please give us your general over-view of the current progress in the treatment of alcoholic hepatitis?
国际肝病：您能给我们概括介绍一下目前治疗酒精性肝炎的进展吗？
Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept.
研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显著增高。
Alcoholic hepatitis is a serious liver disease that may lead to cirrhosis and carcinoma, and the short-term mortality rate is fairly high in severe patients.
酒精性肝炎往往导致肝硬化及肝癌，其重症患者短期死亡率相当高。
Several research studies have worked to find a successful treatment for alcoholic hepatitis, but no consensus has been reached on the most effective treatment regimen.
已经有一些研究发现了治疗酒精性肝炎成功的治疗方法，但是在最有效的治疗的用药方法上还没有达成一致的意见。
Despite this treatment, 30-35% of patients with acute alcoholic hepatitis still die within a six month period, since the cortisone-based treatment remains insufficient.
尽管这种治疗方法，但仍有30- 35%的急性酒精性肝炎患者死于六个月内，因为可的松为基础的治疗仍然效果不足。
Hepatology Digest: Recently, the clinical trial result for the use of Etanercept for alcoholic hepatitis was published in Gastroenterology, and you were one of the authors.
国际肝病：最近在胃肠病学杂志上发表了酒精性肝炎使用依那西普的临床试验结果，您是作者之一。
Objective Massive necrosis and apoptosis of liver cells is the common feature of different kinds of liver diseases, such as viral hepatitis, alcoholic hepatitis, autoimmune hepatitis, etc.
目的：在自身免疫性肝炎和病毒性肝炎引起的肝损伤发病过程中，肝细胞的坏死和凋亡是共同特点。
A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol.
梅奥诊所的一项新的研究发现依那西普药物治疗酒精性肝炎，一种酒精过量导致的急性肝脏炎性改变是无效的。
An increasing number of severely ill acute alcoholic hepatitis patients, often superimposed on cirrhosis, are being seen in our hospitals and cause much morbidity, mortality and health service costs.
我在我们医院中看到越来越多的急性酒精性肝炎（日后大都转化为肝硬化）患者，他们会导致各种疾病的发病率和死亡率的升高，同时也消耗掉了许多宝贵的健康资源。
He said the study "gives some credence to the idea that this actually amplifies the inflammation and, therefore, by targeting it, you may have another therapeutic intervention in alcoholic hepatitis."
他认为这项实验提供了一些可信的想法，它确实放大了炎症反应，所以以它为靶点可能成为治疗酒精性肝炎的一个新手段。
Conclusion Hepatitis history, diabetic, HBV positive marker, alcoholic dependence or age above 60 years is risk factors of hepatic toxicity of antituberculosis agents.
结论既往肝炎病史、糖尿病史、乙肝病毒标志物阳性、年龄60岁以上、酒精依赖等是抗结核药致肝损害危险因素。
The median age was 56, 47% had alcoholic cirrhosis and 39% had hepatitis B or C.
平均年龄在56岁，酒精性肝硬化患者占47%，乙型肝炎和丙型肝炎患者共占39%。
Alcoholic liver disease has become the main cause of liver injury following the virus hepatitis, and its prevention and cure has become an important medical task.
酒精性肝损伤已成为继病毒性肝炎后的主要肝损伤病因，因此酒精性肝病的防治已经成为重要的医疗课题。
To evaluate the efficacy of diisopropylamine dichloroacetate (Ganle) injection on chronic hepatitis companied with alcoholic liver disease.
观察应用复方二氯醋酸二异丙胺治疗慢性病毒性肝炎合并酒精性肝损伤的临床疗效。
Results:Compared with nomal subjects, all patients with alcoholic fatty liver and no-alcoholic fatty liver had apparent insulin resistance; however, others that induced by hepatitis virus hadn't IR.
结果：酒精性脂肪肝、非酒精性脂肪肝患者与健康对照组比较均存在明显的胰岛素抵抗，而肝炎相关性脂肪肝与健康对照比较则不明显。
We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.
我们及其他研究者最近得出的这一结论适用于多种肝脏疾病，包括乙型慢性病毒性肝炎、丙型慢性病毒性肝炎、酒精性肝病和非酒精性脂肪肝。
We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.
我们及其他研究者最近得出的这一结论适用于多种肝脏疾病，包括乙型慢性病毒性肝炎、丙型慢性病毒性肝炎、酒精性肝病和非酒精性脂肪肝。
应用推荐